Skip to main content Skip to secondary navigation


Main content start

Built around a partnership between Sarafan ChEM-H, an interdisciplinary research institute, and Stanford Medicine, encompassing the School of Medicine and the hospitals and clinics of Stanford Health Care, the Innovative Medicines Accelerator (IMA) will provide researchers access to the technology, resources, expertise, and funding to advance their discoveries to impact human health. The IMA plays a key role in Stanford's Long-Range Vision of accelerating solutions to the world's most pressing problems.  

What is the Innovative Medicines Accelerator?


The Innovative Medicines Accelerator builds on and expands existing programs and adds new resources to help Stanford investigators turn their good ideas into effective drugs for people.